Hemp Rules: A federal crackdown due Dec. 11 is pushing Wisconsin businesses to pull hemp products containing THC, including some CBD blends. Senators are weighing bills to regulate these products instead of banning them, while opponents threaten to block funding legislation that keeps them legal. State Policy: Texas Gov.-elect Gina Hinojosa says she plans to reverse the state’s ban on selling hemp-derived THC products to people under 21. North Carolina’s cannabis council is also urging rules for intoxicating THC products, citing gaps in age limits, testing and oversight. Medical Cannabis: New York’s annual symposium brings clinicians and researchers together to discuss patient safety and emerging research as medical cannabis gains wider healthcare attention. CBD Research: Trait Biosciences reports its water-soluble CBD82S showed about 25 times the apparent half-life of conventional CBD in a human liver microsome model; the in-vitro result does not establish effects in patients.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Hemp Rules: U.S. businesses are bracing for federal restrictions on hemp-derived THC products due Dec. 11, with some already clearing shelves. Industry groups and veterans are urging Congress to regulate the products rather than ban them. Texas Shift: Election gains have revived the push for adult-use cannabis: lawmakers have filed bills to legalize, tax and regulate it, though support in the state Senate remains uncertain. Market Access: Boots has begun offering medical-cannabis prescriptions in a UK first, while Costa Rica is moving cannabis and hemp cultivation permits online. Consumer Safety: A Colorado study found just 14% of dispensary products carried all required label information, raising concerns about stale stock and inaccurate potency claims.
Federal Hemp Rules: A new federal law could remove many hemp-derived THC products from shelves by Dec. 11. Veterans’ groups and industry advocates are urging Congress to regulate the products rather than ban them, while businesses face growing uncertainty. State Policy: Illinois’ new hemp law limits THC in products sold outside dispensaries, and Kentucky growers warn the federal deadline could put licensed farms at risk. Massachusetts regulators, meanwhile, approved cannabis retailers’ use of drive-throughs under existing security rules. Medical Cannabis: UK pharmacy chain Boots has launched a medical cannabis prescription service, a notable step toward wider access. Costa Rica has also moved hemp and cannabis cultivation permits online. Health Research: A review of 149 studies involving more than 71,000 people found cannabis use was associated with psychosis starting about 2.5 years earlier on average; the results show an association, not proof that cannabis causes psychosis.
Hemp Rules: A Dec. 11 federal deadline could make many hemp-derived THC products illegal, putting growers and CBD businesses at risk. Kentucky producers say most of the state’s hemp is grown for cannabinoids, while Wisconsin’s incoming Democratic leaders are promising a legalization push. UK Access: Boots is set to become the first UK high-street pharmacy to offer private medical cannabis prescriptions, expanding access for some patients with long-term conditions. Market Outlook: Virginia’s first adult-use market analysis estimates annual sales could reach $1.05 billion and support 107 to 163 dispensaries ahead of a planned 2027 launch. Product Safety: Massachusetts regulators advanced draft testing rules that would require testing before products are sold and clearer labels when products have been treated to address contamination. Health Research: A study linked cannabis use disorder with 57% higher odds of suicidal thoughts, highlighting concerns around problematic use.
Medical Access: Boots has launched a private medical-cannabis service in the UK for eligible patients aged 25 and older with chronic pain, anxiety or insomnia, marking a first for a high-street pharmacy. Product Safety: A University of Colorado study found only one in seven cannabis products met all required labeling rules, while more than half of flower products misstated THC levels. Hemp Rules: Federal limits due Dec. 11 could sharply restrict hemp-derived THC products, putting retailers and manufacturers at risk; businesses and advocates are urging Congress to intervene. Global Medicine: Morocco’s first cannabis-based epilepsy medicine has reached pharmacies, adding to signs of growing medical use beyond North America.
UK Medical Cannabis: Boots has launched SureLeaf, an online service offering eligible patients aged 25 and over cannabis treatment for chronic pain, anxiety or insomnia after conventional treatments fail. Consultants will review and monitor patients, while a University of Nottingham partnership studies outcomes. CBD Medicine: Morocco has introduced its first locally made cannabis-based epilepsy medicine, featuring highly purified CBD. The manufacturer plans to seek export markets after serving domestic patients. Hemp Rules: US businesses are bracing for federal THC limits due Dec. 11 that could remove most hemp-derived products from shelves, including many THC drinks. Health Research: A study of more than 415,000 US adults found cannabis use disorder was associated with 57% higher odds of suicidal thoughts, underscoring concerns around problematic use.
Hemp Rules: The first phase of new U.S. federal restrictions took effect Nov. 12, putting hemp-derived products in doubt as businesses in Missouri and Asheville cut stock, close or fight for a regulatory alternative. Tighter THC limits due in December could add pressure on CBD sellers. Global Industry: South Africa’s eThekwini municipality is advancing a three-year cannabis and hemp commercialisation pilot, while Saint Lucia is working to involve banks in its cannabis industry transition. CBD Research: A study found a popular cannabis-derived supplement had inconsistent anti-inflammatory effects in brain cells, a reminder that health claims need stronger support. U.S. Policy: Democrats are renewing calls for cannabis legalization after midterm gains, though federal and state rules for hemp products remain unsettled.
South Africa: eThekwini is advancing a three-year cannabis and hemp pilot to help local growers enter the formal market, with support for genetics, training and regulatory compliance. In a separate Durban-area operation, police seized 320kg of cannabis. Health Research: A long-term study found cannabis users had poorer objectively measured sleep, challenging its use as a sleep aid. Another study found cannabis was involved in most substance-related emergency visits among adolescents and young adults. U.S. Policy: Tightening rules on hemp-derived THC are forcing some retailers to clear shelves or close, while Illinois has delayed restrictions for some businesses. Democrats are also preparing new cannabis legalization pushes after election gains.
Hemp Rules: New restrictions on hemp-derived THC are reshaping retail. Illinois has begun enforcing a 0.4-milligram-per-container limit, though some businesses covered by a lawsuit get a temporary reprieve; Missouri shops are clearing shelves as its rules take effect. Florida businesses also warn that upcoming federal limits could make most hemp products illegal. Legalization Push: Democrats are renewing calls for cannabis legalization after midterm gains, with new efforts expected in several states. Health Research: A lab study found cannabigerol’s anti-inflammatory effects on brain cells were inconsistent and depended on dose. Separately, a new estimate puts daily cannabis use in Great Britain at 1.2 million people. Product Standards: Massachusetts regulators are considering updated cannabis testing rules, including clearer requirements for failed or remediated products. Another study of 480 legal cannabis products found many labels were missing information.
Hemp Rules: U.S. businesses face mounting uncertainty ahead of federal hemp restrictions due Dec. 11. Missouri shops are clearing shelves and closing, while Illinois has delayed enforcement for some retailers suing over the law. Product Labels: A review of 480 legal cannabis products found 86% lacked required label information, highlighting a consumer-protection gap. Medical Cannabis: Morocco has launched its first cannabis-based epilepsy drug made entirely in the country. CBD Retail: A federal rules change is forcing one CBD store to close, adding to concerns about how new restrictions could reshape the market.
Hemp Rules Tighten: Missouri’s new restrictions have forced hemp retailers to clear shelves and close shops, while broad federal limits are due Dec. 11. Illinois enforcement is delayed for some businesses amid a lawsuit, leaving hemp and CBD sellers facing uncertainty. Medical Cannabis: Morocco has launched its first cannabis-based epilepsy drug made entirely in the country. Brazil’s medical cannabis market has reached $90 million a year as prescriptions rise. Health Research: A study found patients using medical cannabis were twice as likely to stop taking prescription opioids; separate research linked occasional cannabis use with higher stroke odds, though it does not establish cause and effect. Legalization Push: Wisconsin Democrats say full legalization is a priority for 2027, while Texas Democrats have filed recreational legalization bills and New Hampshire Democrats are expected to renew their push.
Federal Hemp Rules: New U.S. restrictions took effect Nov. 12, banning certain synthetic cannabinoids and redefining hemp around a 0.3% total-THC limit. A further cap of 0.4 milligrams of THC and similar compounds per finished product is due Dec. 11, putting many hemp-derived products—and businesses—at risk. Industry Pushback: Shops in Missouri and Illinois are removing or clearing out hemp THC products as state rules take effect, while industry groups press Congress for an alternative. Some businesses warn the changes could force closures; the FDA is also facing criticism for delayed hemp guidance. Product Transparency: A report says 86% of cannabis products lack required label information, renewing calls for clearer details so consumers can make informed choices. Medical Cannabis: A study found patients using medical cannabis were twice as likely to stop prescription opioids, adding to debate over its potential role in pain care.
Hemp Policy: New U.S. restrictions on intoxicating hemp products are squeezing small businesses, with some Missouri operators closing and Illinois retailers facing a ban. In Illinois, a court order temporarily protects businesses that joined a lawsuit, with a hearing set for Nov. 19; a federal THC limit is also looming in December. CBD Business: Hemp-extract company CV Sciences reported third-quarter results, including positive adjusted EBITDA and reduced operating expenses. Research: A study found medical cannabis patients were twice as likely to stop taking prescription opioids, though the finding does not establish that cannabis caused them to do so. Product Oversight: Massachusetts regulators advanced new cannabis testing rules aimed at improving accuracy and consistency.
Hemp THC Rules: A federal change due Dec. 11 would cap total THC at 0.4 milligrams per retail container, putting many hemp drinks above the limit. Minnesota sellers are preparing to cut products, while an Illinois court delay gives some businesses temporary relief. Medical Cannabis: New DEA registrations for state-licensed operators do not allow products to cross state lines, limiting hopes for a national market. Texas Reform: After Democrats’ midterm wins, lawmakers have filed bills to legalize adult-use cannabis, permit home growing and tax sales. Health Watch: A U.S. survey study found occasional cannabis use was linked to 40% higher odds of a reported prior stroke; the finding shows an association, not proof of cause. Global CBD: A European court ruled CBD products cannot be labeled organic, while MediPharm Labs launched an authorized cannabis extract oil in Brazil.
Hemp Rules: Missouri’s restrictions on intoxicating hemp products take effect Thursday, barring unlicensed retailers from selling them. Federal changes also begin Nov. 12 for certain cannabinoids, with broader limits due Dec. 11; the FDA still has not issued guidance required by Congress. State Crackdown: Illinois has agreed to pause enforcement of its hemp THC ban for some businesses suing the state, as retailers face uncertainty over products and inventory. Missouri’s attorney general has also sued four retailers accused of selling marijuana as hemp. CBD Markets: An EU court ruled CBD food products cannot be labeled organic without authorization. In Brazil, MediPharm launched an ANVISA-authorized cannabis extract oil. Industry: MariMed reported third-quarter revenue of $44.2 million, up from $40.8 million a year earlier, while its net loss widened to $3.5 million. Health: A California study found postpartum psychiatric emergency visits were more common among women diagnosed with cannabis use disorder during pregnancy.
Hemp Rules: Illinois has delayed its intoxicating-hemp ban for about 250 businesses suing over the law, but other retailers remain exposed as federal THC restrictions approach in December. Minnesota businesses are already scrambling, and a new federal rule is forcing a Winfield CBD store to close. Global CBD Market: MediPharm Labs has launched an ANVISA-authorized cannabis extract oil in Brazil, expanding its international business. Product Claims: Europe’s top court says CBD foods cannot be labeled organic without authorization, adding a compliance hurdle for brands selling across the EU. Policy Shift: Election gains are fueling fresh legalization efforts, with Texas Democrats filing recreational-use bills and incoming New Hampshire lawmakers discussing reform.
Hemp Policy: Illinois agreed to pause enforcement of its new hemp law against businesses suing the state until Nov. 19, as the measure’s Nov. 12 start date approached. It would restrict many hemp products, while allowing non-intoxicating CBD products only if they contain less than 0.4 milligrams of THC. Federal Rules: Minnesota retailers are also bracing for a federal limit on hemp-derived THC products set to take effect Dec. 11, putting a fast-growing drinks and edibles market at risk. Policy Scrutiny: A report says hemp executive Bret Worley, related by marriage to former White House chief of staff Susie Wiles, deleted posts touting his role in securing a delay to the federal ban; a former administration adviser has accused Wiles of influencing hemp policy for family interests. CBD Labeling: An EU court ruling says CBD foods cannot be labeled organic without authorization, adding another regulatory hurdle for the market.
Hemp Rules: U.S. hemp businesses face mounting uncertainty as a federal ban on many hemp-derived THC products approaches. Illinois businesses are suing to block state restrictions, while a Texas appeals court has postponed arguments on the state’s hemp rules until newly elected judges take office. Patient Access: In South Africa, medical cannabis patients say a reported halt to new Section 21 approvals is threatening access to treatment, including for children with drug-resistant epilepsy. Health Research: A study linked cannabis use to higher mortality among people with alcohol-associated hepatitis; the finding signals an association, not proof that cannabis caused the deaths. Industry Finance: St Kitts and Nevis has opened a compliant banking route for licensed medicinal cannabis businesses, with a seed-to-bank tracking system intended to support oversight and transparency.
Hemp Policy: Willie Nelson urged Congress to regulate, not ban, hemp before federal restrictions take effect Dec. 11, warning they could hit farmers, businesses and consumers. States are also tightening limits on hemp-derived THC products. Health Research: A multinational study linked cannabis use with roughly 2.5 times higher mortality among patients hospitalized with alcohol-associated hepatitis; the finding shows an association, not proof that cannabis caused the deaths. Market & Regulation: Election results have renewed hopes for adult-use legalization in Pennsylvania and opened a political window for Texas hemp businesses, though federal limits remain a looming challenge. In Europe, a court ruled CBD foods cannot carry an organic label without authorization. Youth Education: Minnesota educators are receiving new guidance on discussing cannabis risks with students as school education requirements take effect.
Medicinal Cannabis Banking: Licensed operators in St. Kitts and Nevis could gain access to banking through the national bank, easing a longstanding hurdle for the sector. Hemp Rules: US restrictions on hemp-product sales are tightening, with Illinois businesses bracing for a ban and federal action looming. Industry Finance: Safe Harbor Financial reported third-quarter revenue up 6.5% to $1.95 million, while client deposits rose to $112 million. Health Research: New studies link cannabis use with higher odds of stroke and cardiovascular disease, adding to scrutiny of potential health risks. CBD Regulation: An EU court ruled that CBD food products cannot be labeled organic without authorization.
Sign up for:
Cannabidiol News Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.